A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma-Reference-Cited by-同舟云学术

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma

Published:2017-11-20 Issue:1 Volume:103 Page:67-76
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Raju G.K.¹,Gurumurthi Karthik¹,Domike Reuben¹,Kazandjian Dickran²,Landgren Ola³,Blumenthal Gideon M.²,Farrell Ann²,Pazdur Richard²,Woodcock Janet²

Affiliation:

1. Light Pharma, Inc., Massachusetts Institute of Technology; Cambridge Massachusetts USA

2. U.S. Food and Drug Administration, Center for Drug Evaluation and Research; National Cancer Institute; Silver Spring Maryland USA

3. Memorial Sloan Kettering Cancer Center; New York New York USA

Funder

Memorial Sloan Kettering Core Grant

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference51 articles.

1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics Health, United States, 2010: With Special Feature on Death and Dying 2011

2. The PCAST report: impact and implications for the pharmaceutical industry;Morris;Clin. Pharmacol. Ther.,2013

3. The PCAST Report on Pharmaceutical Innovation: implications for the FDA;Woodcock;Clin. Pharmacol. Ther.,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A benefit risk approach in cutoff determination for diagnostic tests;Clinica Chimica Acta;2024-06

2. Drug development for movement disorders;Handbook of Digital Technologies in Movement Disorders;2024

3. Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland;Future Oncology;2023-09

4. The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches;International Journal of Molecular Sciences;2022-05-08

5. Optimal dose‐finding for efficacy–safety models;Biometrical Journal;2021-04-08